抑制 mTOR 信号通路减轻颗粒细胞损伤:使用 mTORC1 抑制剂依维莫司(RAD001)处理培养的小鼠颗粒细胞,发现 p - Rps6 表达降低,γ - H2AX 阳性颗粒细胞比例减少,表明 mTOR 抑制对 DNA 损伤和细胞凋亡有保护作用。在体内实验中,注射 RAD001 和 CTX 的小鼠,其颗粒细胞中 ...
乳腺癌是女性中最常见的癌症类型,全球每年确诊超过200万例,2020年中国的新发病例约42万,HR+乳腺癌亚型约占所有乳腺癌的70%,患者基数十分庞大。PIK3CA突变是乳腺癌的重要驱动基因之一,在乳腺癌中占30%-40%,中国乳腺癌患者PIK3CA ...
Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related mortality worldwide. Current treatment modalities are few or ...
2 天
MedPage Today on MSNMixed Results for Therapeutic Candidates for Platinum-Resistant Ovarian CancerPromising therapies for platinum-resistant ovarian cancer produced mixed results in separate trials. The AKT inhibitor ...
南方+客户端 on MSN1 天
乳腺抗癌药上新!首个靶向PIK3CA突变创新药伊那利塞获批近日,中国国家药品监督管理局(NMPA)正式批准伊那利塞片联合哌柏西利和氟维司群,适用于内分泌治疗耐药(包括在辅助内分泌治疗期间或之后出现复发)、PIK3CA突变、激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性的局部晚期或转移性乳腺癌成人患者。
Metastatic breast cancer is complex, requiring holistic care and ongoing treatment, with varying prognosis depending on ...
DAX Futures 23110.00 162.00 0.71% ...
PR+ breast cancer responds well to hormone therapy, underscoring the need for molecular insight and targeted treatment ...
5 天
Barchart on MSNPavella - Undiscovered Biotechnology StockYour FREE insider update on the biggest news stories and investing trends, delivered midday TheChart of the Day belongs to ...
After hours: March 14 at 4:07:59 PM EDT Loading Chart for PVLA ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果